Biomaterial Database

The therapeutic evaluation of cortisone applied topically in ophthalmic diseases. 1952

J F MINNES

UI	MeSH Term	Description	Entries
D003348	Cortisone	A naturally occurring glucocorticoid that has been used in replacement therapy for ADRENAL INSUFFICIENCY and as an anti-inflammatory agent. Cortisone itself is inactive; it is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726)	17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate,Adreson,Cortisone Acetate,Cortone Acetate
D005128	Eye Diseases	Diseases affecting the eye.	Eye Disorders,Eye Disease,Eye Disorder

Related Publications

J F MINNES

Pharmacokinetics of topically applied ophthalmic drugs.

January 1982, Survey of ophthalmology,

J F MINNES

Modeling the kinetics of topically applied ophthalmic agents.

August 1991, Optometry and vision science : official publication of the American Academy of Optometry,

J F MINNES

Ocular bioavailability of topically applied ophthalmic drugs.

January 1983, American pharmacy,

J F MINNES

The response of ophthalmic arterial pressure to topically applied clonidine.

July 1978, Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology,

J F MINNES

Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.

February 1978, American journal of ophthalmology,

J F MINNES

Local sue of cortisone in ophthalmic diseases.

March 1951, A.M.A. archives of ophthalmology,

J F MINNES

The efficiency of tropicamide applied topically using a novel ophthalmic delivery system.

January 1997, Eye (London, England),

J F MINNES

Improving the therapeutic index of topically applied ocular drugs.

April 1984, Archives of ophthalmology (Chicago, Ill. : 1960),